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Abstract
Purpose Low yield of invasive coronary angiography and
unnecessary coronary interventions have been identified as
key cost drivers in cardiology for evaluation of coronary
artery disease (CAD). This has fuelled the search for non-
invasive techniques providing comprehensive functional
and anatomical information on coronary lesions. We have
evaluated the impact of implementation of a novel
hybrid cadmium-zinc-telluride (CZT)/64-slice CT camera
into the daily clinical routine on downstream resource
utilization.
Methods Sixty-two patients with known or suspected CAD
were referred for same-day single-session hybrid evaluation
with CZT myocardial perfusion imaging (MPI) and coro-
nary CT angiography (CCTA). Hybrid MPI/CCTA images
from the integrated CZT/CT camera served for decision-
making towards conservative versus invasive management.
Based on the hybrid images patients were classified into
those with and those without matched findings. Matched
findings were defined as the combination of MPI defect with
a stenosis by CCTA in the coronary artery subtending the
respective territory. All patients with normal MPI and CCTA
as well as those with isolated MPI or CCTA finding or
combined but unmatched findings were categorized as “no
match”.
Results All 23 patients with a matched finding underwent
invasive coronary angiography and 21 (91%) were revascu-
larized. Of the 39 patients with no match, 5 (13%, p<0.001
vs matched) underwent catheterization and 3 (8%, p<0.001
vs matched) were revascularized.
Conclusion Cardiac hybrid imaging in CAD evaluation has
a profound impact on patient management and may contrib-
ute to optimal downstream resource utilization.
Keywords Downstream resource utilization . CZT.
SPECT. Cardiac hybrid imaging
Introduction
In clinical practice diagnosis of coronary artery disease
(CAD) has been based on the presence of luminal narrowing
of greater than 50% documented by invasive coronary an-
giography catheterization (CATH). However, it has been
recognized over the last decade that many factors other than
lumen size and its narrowing, which cannot be comprehen-
sively elucidated by coronary angiography alone, may de-
termine whether or not an anatomical coronary lesion
induces ischaemia. Therefore, decision-making towards
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revascularization without proof of ischaemia has been re-
cently challenged. In fact, modern guidelines for coronary
revascularization [1] stipulate that comprehensive evalua-
tion including proof of ischaemia is mandatory for prognos-
tically relevant target vessel revascularization in chronic
stable CAD.
Nuclear myocardial perfusion imaging (MPI) is a well-
established method for the evaluation of myocardial ischae-
mia and coronary computed tomography angiography
(CCTA) has been established over the past years as a clinical
tool for the assessment of coronary anatomy. The combina-
tion of MPI with CCTA has been found to be a valuable
gatekeeper for invasive coronary angiography [2] and may
help to increase the low yield of elective invasive diagnostic
coronary angiography (currently less than 40%) [3]. Cardiac
hybrid imaging has emerged as one of the latest methodo-
logical advancements, integrating information on anatomy
(CCTA) with that from MPI into hybrid images [4]. This
allows to directly relate individual myocardial perfusion
territories to the subtending coronary arteries. Most studies
on hybrid MPI/CT imaging are based on fusion of data from
a separate gamma camera and a stand-alone CT scanner, as
the unfavourable discrepancy of scan length (short CT and
long MPI acquisition time) was hampering the widespread
use of hybrid single photon emission computed tomography
(SPECT)/CT devices in daily clinical routine. With the
introduction of new gamma cameras using a cadmium-
zinc-telluride (CZT) detector technique [5–8], scan time
has been reduced substantially down to a few minutes [9,
10]. This has paved the way for hybrid SPECT/CT scanners
integrating a CZT gamma camera with a high-end 64-slice
CT device and has increased the interest in cardiac fusion
imaging, further supported by recent results confirming the
diagnostic strength [4, 11] and the prognostic value [12] of
cardiac hybrid imaging. However, data on the added clinical
value of hybrid cardiac CZT/CT imaging in the decision-
making for the appropriate treatment strategy are lacking.
The aim of the present study was to evaluate in the daily
clinical routine the impact of hybrid cardiac MPI and CCTA
imaging obtained with an integrated ultrafast CZT/CT de-
vice on downstream resource utilization such as invasive
coronary angiography and revascularization.
Materials and methods
Patients and study protocol
We included 62 patients without a history of prior coronary
artery bypass graft (CABG) who were consecutively re-
ferred for the assessment of known or suspected CAD for
a same-day single-session hybrid scan with CZT MPI and
CCTA to obtain hybrid cardiac images. All patients were
scanned on a CZT/64-slice CT hybrid camera (Discovery
NM/CT 570c, GE Healthcare), and the integrated CZT/CT
images were reported to the referring physicians who made
a decision towards invasive CATH versus conservative
management based on the hybrid imaging finding on the
one hand and including the clinical history and the symp-
toms on the other hand. Similarly, in the catheterization
laboratory the interventional cardiologist based his/her de-
cision towards revascularization on the hybrid images and
the clinical history, integrating the angiographic findings
including fractional flow reserve (FFR) at the operators’
discretion into the clinical decision-making. Downstream
resource utilization within 60 days triggered by the hybrid
imaging was assessed, including decision for conservative
treatment, invasive angiography and revascularization pro-
cedure (CABG or percutaneous coronary intervention, PCI).
From each study participant, written informed consent was
obtained for the use of their imaging and clinical data for
research purposes as approved by the Institutional Review
Board.
Image acquisition
All patients underwent a 1-day pharmacological stress/rest
SPECT MPI protocol according to the guidelines of the
European Association of Nuclear Medicine [13] with aden-
osine (0.14 mg/kg per min over 6 min) while in patients with
contraindications to adenosine (n016) we used dobutamine
(incrementally administered, starting at 5 μg/kg per min and
increasing at 1-min intervals to a maximal dose of 60 μg/kg
per min until 85% of the age-predicted heart rate had been
achieved) according to daily clinical routine in our lab.
Approximately 60 min after injection of 99mTc-tetrofosmin
(332±36 MBq), stress MPI images were acquired (5 min)
using the CZT/CT camera. This was followed by acquisition
of rest MPI with the identical acquisition protocol several
minutes [14] after administration of a three times higher
dose of 99mTc-tetrofosmin (955±169 MBq). MPI scans were
acquired using a multi-pinhole collimator (effective diame-
ter aperture of 5.1 mm) and 19 stationary detectors simulta-
neously imaging 19 different views of the heart as
previously reported. In brief, each detector contains 32 ×
32 pixelated (2.46 × 2.46 mm) CZT elements; the system
design allows acquisition without detector or collimator
motion, and a 10% symmetrical energy window at
140 keV was used [9]. A low-dose CT scan was performed
for attenuation correction of SPECT MPI, which also allows
calculation of calcium scoring [15]. Thereafter, all patients
underwent contrast-enhanced CCTA with prospective ECG
triggering as previously reported [16–18]. Intravenous
metoprolol (2.5–25 mg) was administered prior to the ex-
amination if necessary in order to obtain optimal image
quality for CCTA (target heart rate <65 bpm). All patients
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received 2.5 mg isosorbide dinitrate sublingually 2 min prior
to the CCTA scan. MPI and CCTA images were fused on a
dedicated workstation (Advantage Workstation 4.3, GE
Healthcare) projecting the MPI images on the left ventricu-
lar epicardial surface obtained from the CCTA using the
CardIQ Fusion software package (GE Healthcare) as previ-
ously validated [19, 20]. The 3-D volume rendered fusion
images enable a panoramic view of the coronary artery tree
projected onto the left ventricular myocardial perfusion
territories. Cardiac hybrid images can be displayed in stan-
dard anterior, posterior, lateral and apical views and in freely
selectable angles for standardized documentation and
reporting. Effective radiation dose for CCTAwas calculated
from the dose-length product (DLP) using a conversion
coefficient for the chest, k00.014 mSv/(mGy × cm); for
SPECT MPI a conversion factor of 0.0079 mSv/MBq was
used.
Cardiac hybrid image interpretation
Fused MPI and CCTA images were analysed by two expe-
rienced nuclear cardiologists by consensus with regard to
functionally relevant coronary stenoses. For each patient,
myocardial tomograms were grouped into 20 segments.
The following 5-point scoring system was used to grade
the segmental radionuclide uptake: 00normal, 10equivocal,
20moderate, 30severe reduction of radioisotope uptake and
40absence of detectable tracer in a segment. A pathological
scan was defined as one with stress score ≥2 in two or more
segments. If a stress defect was associated with a stress
defect score of 4 with a rest score of 2 or a rest score ≤1,
a scan was classified as reversible perfusion defect. As
patient management should be ischaemia driven according
to best clinical practice, only reversible defects were con-
sidered for the following assignment into “matched” vs “no
match” finding. A matched SPECT/CT hybrid cardiac im-
aging finding was defined as a reversible SPECTMPI defect
in a territory served by a coronary artery with a stenosis
(defined as narrowing of the coronary luminal diameter
≥50%, Fig. 1). All patients with normal SPECT and CCTA
as well as those with isolated CCTA or MPI finding or
combined but anatomically unmatched finding were
categorized as no match.
Invasive coronary angiography data acquisition and analysis
Invasive CATH was performed according to clinical stand-
ards by experienced interventional cardiologists. Segmenta-
tion of the coronary artery tree was performed as described
for CCTA. A coronary stenosis was defined as a luminal
narrowing ≥50%. This was based on visual assessment
reflecting the clinical routine in our and most other
catheterization laboratories worldwide [21, 22]. The FFR
was determined as the ratio of the simultaneously
assessed pressure in the aorta and in the coronary artery
distal to a stenosis during maximal hyperaemia (induced
by intravenous adenosine administration via a central vein
at 140 μg/kg per min) [22].
Fig. 1 Cardiac hybrid image
and angiographic finding.
Coronary artery stenosis (white
arrowhead) in proximal left an-
terior descending artery is shown
in CCTA (a multiplanar and b
curved multiplanar reconstruc-
tion), cardiac hybrid imaging
with normal perfusion at rest (e)
and perfusion defect (pink area)
at stress (c), matching the
territory of the coronary artery
with stenosis (white arrowhead),
and invasive coronary
angiography (d) confirming the
coronary stenosis (white
arrowhead)
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Statistical analysis
Quantitative variables were expressed as mean±standard
deviation and categorical variables as frequencies or percen-
tages. SPSS 19.0 (SPSS, Chicago, IL, USA) was used for
statistical analysis. The chi-square test was applied to com-
pare the revascularization rates between the two different
patient groups. A p value from the chi-square test of less
than 0.05 was considered statistically significant.
Results
All patients (n062) successfully underwent stress/rest CZT
MPI and CCTA using the CZT/CT camera. The patient
characteristics are given in Table 1.
Overall, the CATH rate was 43% in the study population
yielding 96% CAD. CZT revealed 32 patients (52%) with an
abnormal MPI with reversibility in 26 patients, while CCTA
documented a coronary stenosis in 42 patients (68%) ex-
cluding CAD in 20 patients (32%). Three cases with false
positive SPECT were corrected into negative by normal
CCTA findings. Conversely, a coronary stenosis ≥50% on
CCTA but without stress-induced regional perfusion defect
was found in 17 patients, while 19 patients had a normal
finding on both CCTA and MPI. Cardiac hybrid imaging
revealed a matched perfusion defect in 23 patients (38%),
whereas 39 patients (63%) had no matched findings. The
measurement of FFR was performed in 9 patients (in 12
coronary lesions).
During follow-up, all patients with matched cardiac hy-
brid findings (n023) were referred to CATH of whom 21
(91%, Fig. 2) subsequently underwent PCI or CABG. Of the
two patients without revascularization, one had normal cor-
onary arteries by CATH and the second patient had a small
MPI defect and invasive assessment revealed a stenosis with
normal FFR (≥0.8) over two lesions, i.e. in the left anterior
descending artery (0.82) and in the left circumflex artery
(0.89), both of which therefore did not qualify for coronary
revascularization [23]. Only 5 of the 39 patients (13%) with
no matched hybrid finding (Fig. 2) were sent to CATH and 3
(8%) were revascularized. The reasons for referring a patient
to CATH without matched hybrid finding were either
severe CAD (left main or three-vessel disease) ≥80%
(n02) or massively elevated Agatston coronary calcium
scoring (> 1,000; n03). The latter has recently been shown
to unmask obstructive CAD in patients with normal SPECT
MPI [24]. Revascularization was subsequently performed in
three patients despite lack of matched finding as one patient
revealed abnormal FFR over a lesion in the left anterior
descending artery (0.69) and the other patients showed
either severe coronary three-vessel disease or severe steno-
sis of the left main artery. There was a significantly lower
Table 1 Baseline patient characteristics (n062)
Characteristic Value
Male, n (%) 47 (76)
Age (years)
Mean±SD 62±10
Range 40–86
BMI (kg/m2)
Mean±SD 28±5
Range 19–46
Cardiovascular risk factors, n (%)
Obesity (BMI >30 kg/m2) 18 (29)
Diabetes mellitus 10 (16)
Smoking 18 (29)
Hypertension 42 (68)
Dyslipidaemia 35 (56)
Positive family history 22 (35)
Clinical symptoms, n (%)
Typical angina pectoris 20 (32)
Atypical chest pain 3 (5)
Dyspnoea 8 (13)
No cardiac symptoms 31 (50)
Clinical findings, n (%)
Abnormal rest ECG 27 (44)
Abnormal stress ECG 29 (47)
Abnormal echocardiography 4 (6)
Previous cardiac events, n (%)
Myocardial infarction 5 (8)
PCI 22 (35)
Stent implantation 21 (34)
Current cardiac medication, n (%)
Aspirin 46 (74)
Beta-blocker 27 (44)
ACE/angiotensin II inhibitor 28 (45)
Statin 41 (66)
BMI body mass index
Fig. 2 Downstream resource utilization after cardiac hybrid imaging.
CATH coronary angiography catheterization
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downstream CATH resource utilization in patients with no
matched findings versus those patients with matched cardiac
hybrid findings (p<0.001). Due to subclinical CAD (<50%
luminal narrowing) preventive medical intervention was
initiated in one patient, while in one patient such medication
was withdrawn after excluding any lesion by CCTA.
The effective radiation dose for stress/rest SPECT MPI
was 10.2±1.5 mSv, for attenuation correction 0.9±0.1 mSv
and for prospective triggered CCTA 1.8±0.6 mSv.
Discussion
Our results demonstrate that cardiac hybrid imaging with a
CZT/CT device allows efficient comprehensive evaluation
of CAD. This has a profound impact on patient management
and may contribute to optimal downstream resource utiliza-
tion. In the present study we have shown that in 91% of
patients with a matched finding on cardiac hybrid imaging
coronary revascularization was performed, whereas only 8%
of patients without matched cardiac hybrid finding were
revascularized.
With regard to resource utilization the use of hybrid
imaging had a strong impact as 100% of patients with a
match but only 13% of patients without match were referred
for CATH. As a result, in the patient group with a match the
CAD per CATH yield was 96% comparing favourably to the
yield of less than 38% recently reported for a similar elective
large population [3]. The high CAD yield in our study paved
the way for the above-mentioned high rate of revasculariza-
tion per CATH (91%), which is far superior to figures
reported in registries of most European countries, such as
for example Germany (36%) [25].
An appropriate selection of patients who will benefit
from invasive CATH and eventually from revascularization
is crucial not only because of the costs of CATH but also
because of its non-negligible rate of procedural in-hospital
morbidity and mortality [26, 27]. Although it has been
suggested for a long time [28] and repeatedly documented
[22] that for best clinical practice functional assessment of
coronary lesions is mandatory, invasive CATH has remained
not only the gold standard for CAD detection but also for
decision-making for or against the need for revasculariza-
tion. Our results show that hybrid cardiac imaging is an
excellent gatekeeper for further evaluation with CATH. In
fact, the high yield of CAD and revascularization rate per
CATH documents an appropriateness of invasive resource
utilization far beyond that reported from large registries of
routine clinical practice [3, 25]. By contrast, resource utili-
zation was very low in patients with no hybrid match, in
whom a decision towards invasive CATH (n05) was mainly
driven by extensive coronary calcification (> 1,000 Agatston
units), which has recently been shown to unmask CAD in
patients without SPECT MPI abnormalities. Therefore, in the
present study a calcium score >1,000 triggered a CATH
overruling the lack of a matched finding. In three of
these five patients justification to revascularize was supported
either by FFR or the presence of severe multi-vessel disease
including main stem involvement [2]. The clinical value of
comprehensive CAD assessment by hybrid CZT/CT imag-
ing lies in the improvement of evidence-based patient selec-
tion for coronary revascularization [12, 29]. Although
coronary interventions have been shown to successfully
reduce ischaemic symptoms and, therefore, improve
patients’ quality of life, periprocedural adverse events re-
main important considerations, particularly in low-risk pop-
ulations. In stable CAD populations revascularizations have
failed to confer a prognostic superiority compared to opti-
mal medical therapy [30–33]. However, in patients with
moderate to large ischaemia revascularization may be the
most effective strategy to reduce the amount of jeopardized
myocardium and, consequently, improve prognosis [34]. As
hybrid findings have been shown to be superior in predict-
ing adverse events over isolated findings [12], it appears
appropriate that these findings are the predominant target of
revascularization. In this context our results show that the
implementation of a hybrid CZT/CT camera in daily clinical
routine confers an added value for evidence-based decision-
making and optimization of adequate downstream resource
utilization. Patients with intermediate to high pre-test prob-
ability are among those who most likely may benefit from
noninvasive evaluation by hybrid imaging. However, in
view of the fact that most patients referred for elective
invasive coronary angiography reveal normal coronary
arteries, even lower pre-test probability patients may be
candidates for a hybrid approach as long as unnecessary
invasive angiographies can be avoided. A larger study
would be needed to provide final proof of cost-
effectiveness of the hybrid method, which was beyond the
scope of the present pilot study.
We acknowledge the following limitations: A potential
limitation of the present study is the fact that all patients
underwent two noninvasive tests cumulating radiation ex-
posure to the patients. However, several algorithms may be
implemented into hybrid imaging such as for example
stress-only MPI [35] to reduce radiation. In addition, CZT
cameras offer the potential of a low-dose/low-dose 1-day
protocol as the count-rate linearity allows subtraction of the
counts of the first scan avoiding the need for a threefold
increase of the second scan [36]. Finally, although patients
were included consecutively, there was no randomization to
different treatment options due to the observational nature of
this pilot study on the downstream resource utilization.
However, our results support the notion that use of a CZT/
CT hybrid device in the daily clinical routine may favour-
ably affect resource utilization. Nevertheless, this may also
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depend on the awareness of the clinicians about the avail-
ability and performance of hybrid imaging as well as on the
clinical environment accepting noninvasive imaging as
guidance for revascularization.
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